Skip to content
healthcare.dev

ACETAMINOPHEN

NDC 62207-183, ACETAMINOPHEN, tablet, extended release, from Granules India Limited.

Product NDC
62207-183
Status
Listed
Labeler
Granules India Limited
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA211544
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62207-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ACETAMINOPHEN650 mg/1
Package NDCNDC-11Package
62207-183-34622070183341 POUCH in 1 BOX (62207-183-34) / 5 TABLET, EXTENDED RELEASE in 1 POUCH
62207-183-35622070183356 POUCH in 1 BOX (62207-183-35) / 3000 TABLET, EXTENDED RELEASE in 1 POUCH
62207-183-49622070183491000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62207-183-49)
62207-183-51622070183511 BOTTLE in 1 CARTON (62207-183-51) / 10 TABLET, EXTENDED RELEASE in 1 BOTTLE
62207-183-87622070183871 POUCH in 1 BOX (62207-183-87) / 1 TABLET, EXTENDED RELEASE in 1 POUCH
62207-183-976220701839740000 TABLET, EXTENDED RELEASE in 1 DRUM (62207-183-97)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 62207-183 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62207-183 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62207-183. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.